scholarly article | Q13442814 |
P50 | author | Thibaut Larcher | Q37373430 |
P2093 | author name string | Ignacio Anegon | |
Laurence Dubreil | |||
Séverine Ménoret | |||
Flavien Charpentier | |||
Karl Rouger | |||
Mireille Ledevin | |||
Gilles Toumaniantz | |||
Isabelle Leroux | |||
Candice Babarit | |||
Romain Fleurisson | |||
Laetitia Guével | |||
Agnès Hivonnait | |||
Alice Rannou | |||
P2860 | cites work | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions | Q27001159 |
Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation | Q27309883 | ||
Macrophage plasticity and polarization: in vivo veritas | Q29547620 | ||
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial | Q29620043 | ||
Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review | Q33340205 | ||
Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21. | Q33722181 | ||
Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. | Q33847959 | ||
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. | Q34133412 | ||
The Na+/Ca2+ exchanger-1 mediates left ventricular dysfunction in mice with chronic intermittent hypoxia | Q34426798 | ||
Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart | Q34526107 | ||
Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone, and ligament/tendon studies | Q34681027 | ||
Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction | Q35070840 | ||
Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs | Q35475301 | ||
Myoblast transfer in heart failure | Q35724599 | ||
Cellular transplantation: hurdles remaining before widespread clinical use. | Q35742658 | ||
Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction | Q35786316 | ||
Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation. | Q36015171 | ||
Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells. | Q36221133 | ||
Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials | Q36262927 | ||
Human pericytes for ischemic heart repair | Q36609495 | ||
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction | Q36630155 | ||
Muscle-derived stem cell sheets support pump function and prevent cardiac arrhythmias in a model of chronic myocardial infarction. | Q36659319 | ||
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial | Q36694346 | ||
Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132 | Q36757074 | ||
Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myoc | Q36953625 | ||
Stem-cell therapy for cardiac disease | Q37089732 | ||
Cell-Surface Protein Profiling Identifies Distinctive Markers of Progenitor Cells in Human Skeletal Muscle | Q37171530 | ||
Intravenous Followed by X-ray Fused with MRI-Guided Transendocardial Mesenchymal Stem Cell Injection Improves Contractility Reserve in a Swine Model of Myocardial Infarction. | Q37221593 | ||
Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy | Q37253597 | ||
Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice | Q37286681 | ||
Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. | Q37310724 | ||
Regeneration next: toward heart stem cell therapeutics | Q37606681 | ||
Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy | Q37687409 | ||
Cardiac cell therapy: lessons from clinical trials | Q37769840 | ||
Recent developments in cardiovascular stem cells. | Q38283506 | ||
Quantitative proteome profiling of dystrophic dog skeletal muscle reveals a stabilized muscular architecture and protection against oxidative stress after systemic delivery of MuStem cells. | Q38391853 | ||
MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair after Myocardial Ischemia Reperfusion Injury | Q38603141 | ||
Biodistribution and retention of locally administered human mesenchymal stromal cells: Quantitative polymerase chain reaction-based detection of human DNA in murine organs | Q39019498 | ||
Myoblast transplantation improves cardiac function after myocardial infarction through attenuating inflammatory responses | Q42366644 | ||
Cardiac repair using chitosan-hyaluronan/silk fibroin patches in a rat heart model with myocardial infarction | Q43497430 | ||
Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model | Q43659756 | ||
Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction | Q44392643 | ||
Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle. | Q46245053 | ||
Transplantation of autologous fresh bone marrow into infarcted myocardium: a word of caution | Q47630622 | ||
Gap junctional intercellular communication in adipose-derived stromal/stem cells is cell density-dependent and positively impacts adipogenic differentiation | Q47695023 | ||
MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential | Q47839880 | ||
CD82 Is a Marker for Prospective Isolation of Human Muscle Satellite Cells and Is Linked to Muscular Dystrophies | Q49532456 | ||
Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis | Q50729549 | ||
Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches. | Q52714547 | ||
Cardiovascular progenitor-derived extracellular vesicles recapitulate the beneficial effects of their parent cells in the treatment of chronic heart failure. | Q52877053 | ||
Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model. | Q52963392 | ||
Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization. | Q53585286 | ||
Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. | Q54625464 | ||
Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis. | Q55087466 | ||
Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling | Q56777840 | ||
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction | Q57115991 | ||
Cardiopoietic Stem Cell Therapy in Heart Failure | Q57779306 | ||
Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation | Q61776512 | ||
Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias | Q64072294 | ||
Regenerating and denervated human muscle fibers and satellite cells express neural cell adhesion molecule recognized by monoclonal antibodies to natural killer cells | Q67532595 | ||
Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers | Q73933425 | ||
Differential myocardial infarct repair with muscle stem cells compared to myoblasts | Q81123128 | ||
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement | Q83043116 | ||
Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models | Q88456081 | ||
Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways | Q88680551 | ||
Vascular Delivery of Allogeneic MuStem Cells in Dystrophic Dogs Requires Only Short-Term Immunosuppression to Avoid Host Immunity and Generate Clinical/Tissue Benefits | Q88998647 | ||
Therapeutic Advances of Stem Cell-Derived Extracellular Vesicles in Regenerative Medicine | Q90397450 | ||
An acute immune response underlies the benefit of cardiac stem cell therapy | Q91490060 | ||
Effect of neuron-derived neurotrophic factor on rejuvenation of human adipose-derived stem cells for cardiac repair after myocardial infarction | Q91737533 | ||
Implantation of hiPSC-derived Cardiac-muscle Patches after Myocardial Injury in a Guinea Pig Model | Q92745527 | ||
The Analysis of In Vivo Aging in Human Bone Marrow Mesenchymal Stromal Cells Using Colony-Forming Unit-Fibroblast Assay and the CD45lowCD271+ Phenotype | Q92996936 | ||
A viscoelastic adhesive epicardial patch for treating myocardial infarction | Q93112489 | ||
P304 | page(s) | 446-463 | |
P577 | publication date | 2020-06-15 | |
P1433 | published in | Molecular Therapy. Methods & Clinical Development | Q27725341 |
P1476 | title | Human MuStem Cell Grafting into Infarcted Rat Heart Attenuates Adverse Tissue Remodeling and Preserves Cardiac Function | |
P478 | volume | 18 |
Search more.